GlassScriptPhysician profile
Catherine Spratt Turner
NPI 1578526380
$27,340.89
in general payments reported to CMS, 2019-2025
78 companies · $4,682 in 2025
The $4,682 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,323 · 2020: $3,488 · 2021: $3,979 · 2022: $3,377 · 2023: $4,200 · 2024: $4,292 · 2025: $4,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $37.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,136.95 |
| Education | $37.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,665.95 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $2,457.37 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,699.20 | 2019-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $1,614.21 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $1,330.14 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,150.25 | 2019-2025 | Xifaxan, Cycloset |
| Amgen INC. | $1,144.77 | 2019-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,000.94 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Pfizer INC. | $955.15 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $855.35 | 2021-2025 | |
| Astellas Pharma US INC | $743.48 | 2019-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $730.76 | 2019-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $725.98 | 2019-2025 | Spravato, Xarelto |
| Merck Sharp & Dohme LLC | $692.25 | 2019-2025 | Verquvo, Lagevrio, Belsomra |
| Axsome Therapeutics, INC. | $578.71 | 2022-2025 | Sunosi, Auvelity |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $503.18 | 2022-2024 | Azstarys, Azstarys |
| Amarin Pharma, INC. | $503.12 | 2019-2023 | |
| Esperion Therapeutics, INC. | $409.66 | 2021-2024 | Nexletol |
| Allergan, INC. | $365.12 | 2019-2020 | |
| Radius Health, INC. | $349.29 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $346.82 | 2019-2023 | Ajovy, Austedo |
| Sumitomo Pharma America, INC. | $344.28 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $338.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $326.00 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $285.37 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Abbott Laboratories | $271.68 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Almatica Pharma LLC | $267.79 | 2021-2025 | Loreev Xr |
| Lundbeck LLC | $253.85 | 2020-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $248.19 | 2022-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $246.24 | 2023-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $245.65 | 2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $239.95 | 2021-2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $213.46 | 2019-2024 | Jornay Pm |
| Jazz Pharmaceuticals INC. | $181.43 | 2020-2022 | |
| Harmony Biosciences LLC | $177.24 | 2023-2024 | Wakix |
| Sunovion Pharmaceuticals INC. | $168.91 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $154.21 | 2025 | Caplyta |
| Ardelyx, INC. | $144.14 | 2024 | Ibsrela |
| Neos Therapeutics, LP | $125.81 | 2021-2023 | Adzenys Xr-Odt |
| Scilex Pharmaceuticals INC. | $112.75 | 2021-2022 | |
| Mylan Specialty L.P. | $77.79 | 2022-2023 | Yupelri |
| Sanofi-Aventis U.S. LLC | $77.39 | 2019-2020 | |
| Eisai INC. | $70.32 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $69.64 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $64.23 | 2024-2025 | Voquezna |
| Shield Therapeutics INC | $60.00 | 2025 | |
| Collegium Pharmaceutical, INC. | $58.66 | 2025 | Jornay Pm |
| Optinose US, INC. | $47.85 | 2020-2021 | |
| Verona Pharma, INC. | $43.39 | 2025 | Ohtuvayre |
| Bausch Health US, LLC | $39.03 | 2020-2021 | |
| Acerus Pharmaceuticals Corporation | $38.17 | 2022 | |
| Tris Pharma INC | $37.65 | 2023 | Dyanavel Xr |
| Impel Pharmaceuticals INC. | $33.59 | 2022-2023 | Trudhesa |
| Clarus Therapeutics INC. | $32.81 | 2021 | |
| Idorsia Pharmaceuticals US INC | $32.40 | 2023 | Quviviq |
| Adlon Therapeutics L.P. | $28.02 | 2020-2021 | |
| Intra-Sana Laboratories | $27.30 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Seqirus USA INC | $25.23 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Ibsa Pharma INC. | $24.98 | 2022 | |
| Linus Health, INC. | $21.84 | 2023 | |
| Agile Therapeutics, INC. | $19.05 | 2021 | |
| Galderma Laboratories, L.P. | $18.57 | 2021 | |
| Theracosbio, LLC | $17.78 | 2023 | Brenzavvy |
| Tolmar, INC. | $16.36 | 2023 | |
| Inspire Medical Systems, INC. | $16.20 | 2024 | Inspire |
| Avion Pharmaceuticals | $15.77 | 2023 | Balcoltra |
| Corcept Therapeutics | $15.75 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.16 | 2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $15.10 | 2021 | |
| Dexcom, INC. | $14.13 | 2021 | |
| Assertio Therapeutics, INC. | $14.08 | 2020 | |
| Aytu Biopharma, INC. | $13.89 | 2020 | |
| Genentech USA, INC. | $12.79 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.64 | 2021 | |
| Zyla Life Sciences, INC. | $12.35 | 2020 | |
| Horizon Therapeutics Plc | $12.18 | 2021 | |
| Vistapharm, INC. | $11.23 | 2021 | |
| Mayne Pharma Commercial LLC | $10.53 | 2023 |
Drugs and devices associated with these payments
Airsupra $839Breztri $694Vraylar $643Kerendia $579Farxiga $573Ubrelvy $557Rexulti $475Jardiance $466Xifaxan $465Trelegy Ellipta $443Nurtec Odt $402Azstarys $381Mounjaro $373Sunosi $360Gemtesa $344Veozah $339Eliquis $297Zepbound $286Otezla $279Repatha $279Ingrezza $246Fanapt $246Cologuard Collection Kit $241Comirnaty $217Prevnar 20 $217Jornay Pm $199Trintellix $191Arexvy $187Nexletol $180Wakix $177Auvelity $177Qelbree $167Caplyta $154Freestyle Libre 3 $152Qulipta $151Cycloset $149Ibsrela $144Leqvio $142Wegovy $141Paxlovid $138Loreev Xr $135Abrysvo $130Spravato $127Verquvo $117Zavzpret $106The Cologuard Plus Collection Kit $97.84Trulicity $92.64Shingrix $77.71Trumenba $71.50Spiriva Respimat $65.60Stiolto Respimat $65.60Voquezna $64.23Entresto $60.90Accrufer $60.00Adzenys Xr-Odt $51.62Evenity $44.15Prolia $44.15Ohtuvayre $43.39Livalo $39.48Seglentis $39.05Yupelri $38.36Dyanavel Xr $37.65Quviviq $32.40Ozempic $30.00Emgality $29.09Fasenra $28.00Reltone 400 Mg $27.30Reltone 200 Mg $27.30Glycate $27.30Fluad Quadrivalent $25.23Flucelvax Quadrivalent $25.23Lagevrio $24.67Xarelto $24.03Prevnar 13 $22.88Core Cognitive Evaluation $21.84Trudhesa $21.43Steglujan $21.10Belsomra $21.10Steglatro $21.10Proclaim $20.75Brenzavvy $17.78Jatenzo $16.36Inspire $16.20Balcoltra $15.77Zoryve $15.43Vascepa $15.26Opsumit $15.16Uptravi $15.16Austedo $13.50Ajovy $13.50
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Spratt Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.